Clinical Trial Update: Phase I Trial of Vorinostat (MK-0683, SAHA) in Combination With Decitabine in Patients With AML or MDS (MK-0683-055 EXT1) [Phase 1]

View source ↗

Summary

This Phase I clinical trial update reports the combination of Vorinostat (MK-0683, SAHA) with Decitabine in patients with acute myeloid leukemia or myelodysplas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Decitabine (Decitabine)
• Vorinostat (vorinostat)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Leukemia, Myelocytic, Acute Myelodysplastic Syndromes, Myelodysplastic Syndromes | Phase 1 | Status: COMPLETED | Results posted: 2011-08-31